Clinical Trial Update: Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating the combination of decompressive spine radiosurgery and pembrolizumab for epidural spinal tumors and cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Spinal Neoplasms

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Epidural Spinal Tumors, Cancer | EARLY_Phase 1 | Status: TERMINATED